共 50 条
- [1] Ustekinumab maintained clinically meaningful improvement in health-related quality of life in patients with moderate to severe ulcerative colitis: Results from the UNIFI long-term extensionJOURNAL OF CROHNS & COLITIS, 2020, 14 : S094 - S095Sandborn, W. J.Rowbotham, D. S.Leong, R. W. L.Han, C.Zhou, Y.Zhang, H.Johanns, J.Marano, C.Danese, S.
- [2] Ustekinumab Maintained Clinically Meaningful Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease: Results From the IM-UNITI Long-Term ExtensionAMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S404 - S404Sands, Bruce E.Han, ChenglongGasink, ChristopherBin, ZouStephen, TarganSandborn, William J.Feagan, Brian G.
- [3] DOSE ADJUSTMENT IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE UNIFI MAINTENANCE STUDY LONG-TERM EXTENSIONGASTROENTEROLOGY, 2020, 158 (06) : S1204 - S1204Sands, Bruce E.Panaccione, RemoPeyrin-Biroulet, LaurentMarano, Colleen W.O'Brien, Christopher D.Zhang, HongyanZhou, YiyingJohanns, JewelScherl, Ellen J.Leong, Rupert W.Rowbotham, DavidArasaradnam, Ramesh P.Danese, Silvio
- [4] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH USTEKINUMAB IN MODERATE-SEVERE ULCERATIVE COLITIS PATIENTS WITH DELAYED RESPONSE TO USTEKINUMAB INDUCTION: RESULTS FROM THE UNIFI 2-YEAR LONG-TERM EXTENSIONGASTROENTEROLOGY, 2020, 158 (06) : S1201 - S1201Abreu, Maria T.Sands, Bruce E.Leong, Rupert W.Marano, Colleen W.O'Brien, Christopher D.Zhang, HongyanZhou, YiyingJohanns, JewelRowbotham, DavidHisamatsu, TadakazuArasaradnam, Ramesh P.Scherl, Ellen J.Danese, SilvioPeyrin-Biroulet, Laurent
- [5] Efficacy and safety of long-term treatment with ustekinumab in moderate-severe ulcerative colitis patients with delayed response to ustekinumab induction: Results from UNIFI 2-year long-term extensionJOURNAL OF CROHNS & COLITIS, 2020, 14 : S476 - S477Sands, B. E.Abreu, M. T.Leong, R. W. L.Marano, C.O'Brien, C. D.Zhang, H.Zhou, Y.Johanns, J.Rowbotham, D.Hisamatsu, T.Arasaradnam, R. P.Scherl, E.Danese, S.Peyrin-Biroulet, L.
- [6] Long-term (5-year) maintenance of clinically meaningful improvement in health-related quality of life in patients with moderate to severe Crohn's disease treated with ustekinumab in the IM-UNITI long-term extension studyJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 108 - 109Sandborn, William J.Ghosh, SubrataHan, ChenglongGasink, ChristopherZou, BinFeagan, Brian G.
- [7] LONG-TERM (5-YEAR) MAINTENANCE OF CLINICALLY MEANINGFUL IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE TREATED WITH USTEKINUMAB IN THE IM-UNITI LONG-TERM EXTENSION STUDYGASTROENTEROLOGY, 2021, 160 (06) : S558 - S559Sandborn, William J.Ghosh, SubrataHan, ChenglongGasink, ChristopherZou, BinFeagan, Brian G.
- [8] Dose adjustment in patients with moderate-to-severe ulcerative colitis: results from the UNIFI maintenance study long-term extensionJOURNAL OF CROHNS & COLITIS, 2020, 14 : S403 - S403Danese, S.Panaccione, R.Peyrin-Biroulet, L.Marano, C.O'Brien, C. D.Zhang, H.Zhou, Y.Johanns, J.Scherl, E.Leong, R. W. L.Rowbotham, D. S.Arasaradnam, R. P.Sands, B. E.
- [9] Dose adjustment in patients with moderate to severe ulcerative colitis: results from year 3 of the UNIFI maintenance study long-term extensionJOURNAL OF CROHNS & COLITIS, 2021, 15 : S488 - S489Rowbotham, D. S.Scherl, E. J.Sands, B. E.Panaccione, R.Peyrin-Biroulet, L.Zhang, H.Miao, Y.Leong, R. W.Afif, W.Arasaradnam, R. P.Danese, S.Marano, C.
- [10] Efficacy of Ustekinumab for Ulcerative Colitis in Patients Through 3 Years: UNIFI Long-term ExtensionAMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S315 - S315Abreu, Maria T.Rowbotham, David S.Danese, SilvioSandborn, William J.Miao, YeZhang, HongyanPanaccione, RemoHisamatsu, TadakazuScherl, EllenLeong, RupertArasaradnam, RameshAfif, WaqqasPeyrin-Biroulet, LaurentSands, Bruce E.Marano, Colleen